RecruitingNot ApplicableNCT06736600
Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial
Sponsor
M.D. Anderson Cancer Center
Enrollment
45 participants
Start Date
Apr 18, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
A behavioral trial aimed at helping patients identify what matters most to them and is part of a larger effort to pivot from disease-oriented care to whole-person care.
Eligibility
Min Age: 18 Years
Inclusion Criteria11
- Provision of signed and dated electronic informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Age 18 or older.
- Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy.
- Access to smartphone and internet for participating in a technology-based intervention
- Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date.
- English-speaking
- Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months
- No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months.
- Resides in the Houston Metroplex
- A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition
Exclusion Criteria11
- Provision of signed and dated electronic informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Age 18 or older.
- Documented diagnosis of chemotherapy-induced peripheral neuropathy meeting the following criteria: 1) onset associated with timing of neurotoxic chemotherapy and 2) symptomatic reports of peripheral neuropathy.
- Access to smartphone and internet for participating in a technology-based intervention
- Upcoming in-person appointment in the Main Hospital Pain Management Clinic 4-6 weeks from the consent date.
- English-speaking
- Pain or bothersome symptoms present most days of the week at an average of ≥4/10 on the Numeric Rating Scale for the past 3 months
- No longer receiving cancer treatment or has been on stable maintenance treatment for the past 3 months.
- Resides in the Houston Metroplex
- A score ≤7 on the validated Six Item Cognitive Impairment Test (6CIT) for unimpaired cognition
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALGoal Attainment Scaling (GAS)
Goal-setting tele-coaching and the well-studied Patient Priorities Care framework will assist participants with bothersome CIPN identify their most important health goals and scale them into specific, measurable, achievable, relevant, and time-bound (SMART) goals
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06736600
Related Trials
Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.
NCT066166491 location
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
NCT074233904 locations
Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
NCT070959982 locations
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
NCT069592776 locations
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
NCT067448161 location